Literature DB >> 25577962

Use of metabolomics to elucidate the metabolic perturbation associated with hypertension in a black South African male cohort: the SABPA study.

Cynthia A van Deventer1, Jeremie Z Lindeque1, Peet J Jansen van Rensburg1, Leoné Malan2, Francois H van der Westhuizen1, Roan Louw3.   

Abstract

There is concern about the increasing burden of essential hypertension in urban-dwelling black South Africans, especially males. Several studies have investigated urbanization and hypertension in South Africans, but in-depth metabolomics studies on these urbanized hypertensives are still lacking. We aimed to investigate hypertension via two metabolomics methods in order to explore underlying biological mechanisms, demonstrating the effectiveness of these methods in cardiovascular research. A comprehensive characterization of a group (n = 25) of black male South Africans was performed using urinary gas chromatography-mass spectrometry and liquid chromatography-mass spectrometry metabolic profiling in conjunction with 24-hour ambulatory blood pressure readings and anthropometric, clinical, and biochemical markers. Average 24-hour blood pressure readings served as the grouping variable, and test subjects were divided into quintiles. Statistical analyses were performed on Quintile 1 (normotensive subjects) and Quintile 5 (extreme hypertensive subjects). After feature selection was performed, several metabolites and cardiometabolic risk markers, including abdominal obesity and markers of liver damage, inflammation, and oxidative stress were significantly perturbed in Quintile 5 (hypertensives) compared with Quintile 1 (P < .05). Pathway analysis revealed perturbations in several systems involved in ethanol metabolism via shifted global NADH/NAD(+) ratio. Although alcohol abuse has been established as a risk factor for hypertension, this study illustrated a metabolic perturbation associated with alcohol abuse, contributing to the development of hypertension-possibly by altering bioenergetics through a shift in the NADH/NAD(+) ratio. Following this finding, future intervention studies on alcohol moderation, as well as further enhancement of metabolomics methods in cardiovascular research are highly recommended.
Copyright © 2015 American Society of Hypertension. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alcohol abuse; cardiometabolic disease; hypertension; metabolomics

Mesh:

Substances:

Year:  2014        PMID: 25577962     DOI: 10.1016/j.jash.2014.11.007

Source DB:  PubMed          Journal:  J Am Soc Hypertens        ISSN: 1878-7436


  8 in total

1.  Hypothalamic-pituitary-adrenal-axis dysregulation and double product increases potentiate ischemic heart disease risk in a Black male cohort: the SABPA study.

Authors:  Leoné Malan; Christiaan E Schutte; Ala'a Alkerwi; Saverio Stranges; Nicolaas T Malan
Journal:  Hypertens Res       Date:  2017-02-09       Impact factor: 3.872

2.  Identifying a metabolomics profile associated with masked hypertension in two independent cohorts: Data from the African-PREDICT and SABPA studies.

Authors:  Michél Strauss-Kruger; Ruan Kruger; Esmé Jansen Van Vuren; Adriaan Jacobs; Roan Louw; Carina Mels
Journal:  Hypertens Res       Date:  2022-09-02       Impact factor: 5.528

3.  Applications of Chromatography-Ultra High-Resolution MS for Stable Isotope-Resolved Metabolomics (SIRM) Reconstruction of Metabolic Networks.

Authors:  Qiushi Sun; Teresa W-M Fan; Andrew N Lane; Richard M Higashi
Journal:  Trends Analyt Chem       Date:  2019-10-01       Impact factor: 12.296

4.  An Ion Chromatography-Ultrahigh-Resolution-MS1/Data-Independent High-Resolution MS2 Method for Stable Isotope-Resolved Metabolomics Reconstruction of Central Metabolic Networks.

Authors:  Qiushi Sun; Teresa W-M Fan; Andrew N Lane; Richard M Higashi
Journal:  Anal Chem       Date:  2021-01-22       Impact factor: 6.986

5.  Molecular pathways associated with blood pressure and hexadecanedioate levels.

Authors:  Cristina Menni; Sarah J Metrustry; Georg Ehret; Anna F Dominiczak; Phil Chowienczyk; Tim D Spector; Sandosh Padmanabhan; Ana M Valdes
Journal:  PLoS One       Date:  2017-04-12       Impact factor: 3.240

6.  Serum metabolites reflecting gut microbiome alpha diversity predict type 2 diabetes.

Authors:  Cristina Menni; Jialing Zhu; Caroline I Le Roy; Olatz Mompeo; Kristin Young; Casey M Rebholz; Elizabeth Selvin; Kari E North; Robert P Mohney; Jordana T Bell; Eric Boerwinkle; Tim D Spector; Massimo Mangino; Bing Yu; Ana M Valdes
Journal:  Gut Microbes       Date:  2020-06-24

7.  An untargeted metabolomics study of blood pressure: findings from the Bogalusa Heart Study.

Authors:  William J He; Changwei Li; Xuenan Mi; Mengyao Shi; Xiaoying Gu; Lydia A Bazzano; Alexander C Razavi; Jovia L Nierenberg; Kirsten Dorans; Hua He; Tanika N Kelly
Journal:  J Hypertens       Date:  2020-07       Impact factor: 4.844

Review 8.  An Overview of Metabolic Phenotyping in Blood Pressure Research.

Authors:  Ioanna Tzoulaki; Aikaterini Iliou; Emmanuel Mikros; Paul Elliott
Journal:  Curr Hypertens Rep       Date:  2018-07-10       Impact factor: 5.369

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.